Posted 14 June, 2023
ONCOSEC MEDICAL Inc appointed new CEO
CEO Change detected for ticker Nasdaq:ONCS in a 8-K filed on 14 June, 2023.
In addition to his resignation from the Company's Board of Directors, Dr. Arch tendered his resignation as the Company's President and Chief Executive Officer effective on June 14, 2023, immediately after filing the Petition.
Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of ONCOSEC MEDICAL Inc
Health Care/Life Sciences • Pharmaceuticals
OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered in Ewing, NJ.Market Cap
$0.60K
View Company Details
$0.60K
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Dr. Linda Shi, Dr. Robert Arch, Stephany Foster, Joon Kim, Dr. H. Kim Lyerly, Kevin Smith and Chao Zhou each tendered their resignations as members of the Company's Board of Directors which resignations were effective on June 14, 2023, prior to filing the Petition. The resignations of Dr. Shi, Dr. Arch, Ms. Foster, Mr. Kim, Dr. Lyerly, Mr. Smith and Mr. Zhou are not the result of any disagreements with the Company regarding the Company's operations, policies, or practices. Dr. Shi, Dr. Arch, Ms. Foster, Mr. Kim, Dr. Lyerly, Mr. Smith and Mr. Zhou have all resigned due to the Company's filing of the Petition which effectively eliminates the powers of the Company's Board of Directors. Following the resignations of Dr. Shi, Dr. Arch, Ms. Foster, Mr. Kim, Dr. Lyerly, Mr. Smith, and Mr. Zhou, the Company will have no members serving on its Board of Directors. In addition to his resignation from the Company's Board of Directors, Dr. Arch tendered his resignation as the Company's President and Chief Executive Officer effective on June 14, 2023, immediately after filing the Petition. The resignation of Dr. Arch is not the result of any disagreement with the Company regarding the Company's operations, policies, or practices. Dr. Arch resigned due to the filing of the Petition which effectively eliminates the powers Dr. Arch previously held on behalf of the Company in his role as President and Chief Executive Officer. As a result, the Company no longer has any current executive officers.
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.